Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Mifepristone

EU orphan designation number: EU/3/11/925   
Active ingredient: Mifepristone
Indication: Treatment of hypercortisolism (Cushing´s syndrome) of endogenous origin
Sponsor: FGK Representative Service GmbH
Heimeranstraße 35, D-80339 München, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/10/2011 Centralised Orphan - Designation EMA/OD/073/11 (2011)7902 of 27/10/2011
27/12/2012 Centralised Orphan - Transfer of orphan designation EMA/OD/073/11/T/01 (2012)9812 of 17/12/2012
18/10/2013 Centralised Orphan - Transfer of orphan designation EMA/OD/073/11/T/02 (2013)6967 of 16/10/2013